scispace - formally typeset
R

Raf Schepers

Researcher at National Institute on Drug Abuse

Publications -  8
Citations -  604

Raf Schepers is an academic researcher from National Institute on Drug Abuse. The author has contributed to research in topics: Medicine & Vaccination. The author has an hindex of 3, co-authored 3 publications receiving 361 citations.

Papers
More filters
Journal ArticleDOI

Methamphetamine and Amphetamine Pharmacokinetics in Oral Fluid and Plasma after Controlled Oral Methamphetamine Administration to Human Volunteers

TL;DR: Perceived advantages of oral fluid for verifying METH exposure compared with urine include simpler specimen collection and reduced potential for adulteration, but urine offers higher analyte concentrations and a greater window of detection.
Journal ArticleDOI

Plasma and Oral Fluid Pharmacokinetics and Pharmacodynamics after Oral Codeine Administration

TL;DR: Oral fluid testing is a useful alternative matrix for monitoring codeine exposure with a detection window of 7-21 h for single doses, depending on cutoff concentrations, but because of high variability, oral fluid codeine concentrations did not reliably predict concurrent plasma concentrations.
Journal ArticleDOI

Protection of COVID-19 vaccination and previous infection against Omicron BA.1, BA.2 and Delta SARS-CoV-2 infections

TL;DR: In this paper , the authors employed a test-negative design on S-gene target failure data from community PCR testing in the Netherlands from 22 November 2021 to 31 March 2022 (n = 671,763).
Journal ArticleDOI

Shorter serial intervals in SARS-CoV-2 cases with Omicron BA.1 variant compared with Delta variant, the Netherlands, 13 to 26 December 2021

TL;DR: The SARS-CoV-2 Omicron variant has a growth advantage over the Delta variant because of higher transmissibility, immune evasion or shorter serial interval, and within households, the mean serial interval for SGTF cases was 0.2–0.6 days shorter than for non-SGTF cases.